Thomas Michael Perone serves as Executive at Ovid Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Thomas Michael Perone has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 22, 2024 involved receiving (via award) 28,125 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 22, 2024 | OVID | $0 | Award | 28,125 | $N/A | Discretionary |
Thomas Michael Perone currently holds 28,125 shares of Ovid Therapeutics Inc. (OVID), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas Michael Perone has been a net neutral trader of OVID stock. They have purchased $0 and sold $0 worth of shares.
Thomas Michael Perone's most recent insider trade was on Feb 22, 2024, when they sold 28,125 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted